Carol Mason, MD, FCCPLSUHSC School of Medicine

Administration	Basic Sciences	Clinical Sciences	Centers of Excellence
Admissions Alumni Affairs Community and Minority Health Education Computer Support Continuing Education Dean's Office Faculty & Institutional Affairs Fiscal Affairs Libraries Medical Education Research Student Affairs	Biochemistry & Molecular Biology Cell Biology & Anatomy Genetics Microbiology, Immunology & Parasitology Pharmacology Physiology	Anesthesiology Dermatology Family Medicine Internal Medicine Emergency Medicine Gastroenterology Physical Medicine & Rehabilitation Neurology Neurosurgery OB/GYN Ophthalmology Orthopaedics Otorhinolaryngology Pathology Pediatrics Psychiatry Radiology Surgery Urology	Alcohol and Drug Abuse Center Cardiovascular Center Center on Healthy Aging Center for Molecular and Human Genetics Epilepsy Center Eye Center Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center Gene Therapy Program Low Vision Center Neurosciences Center The Research Institute For Children Stanley S. Scott Cancer Center

About Us

	Carol Mason, MD, FCCP Professor of Medicine Medical Director of Respiratory Therapy, MCLNO Staff Physician, MCLNO, Ochsner 1901 Perdido Street Suite 3205 New Orleans, LA 70112 Phone: (504) 412-1400 (Appointments); (504) 568-4634 (Office) Fax: (504) 568-4295 mason@lsuhsc.edu
Degrees	MD - 1982 Louisiana State University School of Medicine - New Orleans
Bio	Dr. Mason’s research endeavors center around pulmonary host defenses against infection, specifically infection with Mycobacterium tuberculosis, and the impact of alcohol consumption during that infection. Current research focuses on alcohol-induced lung CD4+ lymphocyte abnormalities during murine tuberculous infection. She is a faculty member in the LSUHSC Alcohol Research Center Biomedical Alcohol Research Training Program, an institutional NRSA research training grant. Active collaborations with other investigators are also in place, in which investigations with M. tuberculosis study the means by which the organism may override host defense mechanisms, thereby inducing lymphocyte dysfunction. Preclinical tuberculosis vaccine studies are also being performed in collaborative ventures.
Research Interests	General Pulmonary Diseases Mechanisms of pulmonary host defense against infections
Selected Publications	Badewa AP, Quinton LJ, Shellito JE, and Mason CM. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis. Tuberculosis 85:185-195, 2005. Happel KI, Lockhart E, Mason CM, Porretta E, Keoshkerian E, Odden AR, Nelson S, Ramsay AJ. Pulmonary IL-23 gene delivery increases local T cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 73:5782, 2005. Zea AH, Culotta K, Ali J, Mason C, Park H, Zabeleta J, Garcia LF, Ochoa AC. Decreased expression of CD3 and NF-B in patients with pulmonary tuberculosis (PTB): potential mechanisms and reversibility with treatment. J Infect Dis 194:1385-1393, 2006. Mason C, Porretta E, Zhang P, Nelson S. CD4+CD25+TGF--producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol 148:537-545, 2007. (doi: 10.1111/j.1365-2249.2007.03371.x) Ramirez J, Mason C, Ali J. Use of mefloquine in multi-drug resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient. Curr Ther Res 68:421-429, 2007. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CM, Iwakura Y, Kolls JK. IL-22 mediates mucosal host defense against gram negative bacterial pneumonia. Nat Med 14:275-281, 2008 (advance online, doi:10.1038/nm1710). Ramirez J, Mason C, Ali J. Case of the Month: Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients. In press, Journal of the Louisiana State Medical Society, 2008.